NCI Director Discusses "What Impedes Cancer Research"
In a talk titled "What Impedes Cancer Research?" Dr. Varmus explained how the nearly $90 billion dollars that NCI has spent on research in the last 40 years has changed the understanding of cancer and its prevention, diagnosis, and treatment. But, while this effort has had many benefits—most importantly a decline in cancer death rates—cancer remains a leading cause of death in the United States and the world.
Dr. Varmus discussed the barriers to greater and faster progress against cancer, such as the complex biology of tumors and the difficulties of developing new ways to prevent, diagnose, and treat cancers.
What You Need to Know About Cancer Booklets Updated
Three booklets in NCI's What You Need to Know (WYNTK) series have been updated:
- What You Need To Know About Breast Cancer (html, pdf)
- What You Need To Know About Lung Cancer (html, pdf)
- What You Need To Know About Prostate Cancer (html, pdf)
Booklets in the WYNTK series are for people who have been recently diagnosed with cancer and want to learn about stages, treatment options, sources of support, and follow-up care. The booklets offer lists of questions about treatment options that people can take to their next medical appointment.
The Boletín, NCI's Spanish-Language Newsletter, Turns Three
NCI's monthly Spanish-language newsletter, the Boletín del Instituto Nacional del Cáncer, celebrated its third anniversary last month. The Boletín, a free online publication that includes selected articles from the NCI Cancer Bulletin, features stories about the causes, prevention, diagnosis, and treatment of cancer.
Available on NCI's Spanish-language website, the Boletín publishes between 16 and 18 stories per issue and has more than 2,500 subscribers in the United States and abroad.
The Boletín staff welcomes your feedback. Please share your suggestions as well as topics you'd like to see discussed in future issues. You can also connect with us on Facebook, view informational videos on YouTube, and follow us on Twitter.